|[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]|
FDA: Majority of drug and biological product makers meeting postmarketing requirements and commitments
Tue, 09 Nov 2010 17:19:00 -0600
Most makers of approved drug and biological products are meeting their regulatory obligations and meeting targets for postmarketing studies/clinical trials in a timely manner, according to a study released today by the U.S. Food and Drug Administration (FDA).
Manage your FDA Subscriptions:
U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420